Pfizer expects 2021, 2022 COVID-19 vaccine sales to total at least $65 bln
By Manas Mishra and Michael ErmanNov 2 (Reuters) - Pfizer Inc on Tuesday said it expected 2021 sales of the COVID-19 vaccine it developed with German...
By Manas Mishra and Michael ErmanNov 2 (Reuters) - Pfizer Inc on Tuesday said it expected 2021 sales of the COVID-19 vaccine it developed with German...